SCHEMBL24579782

SCHEMBL24579782

Cc1cc(Cl)c2c(C(C)N)nccc2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 2/20 0.33
▸ CD274 Q9NZQ7 2/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ PSMD14 O00487 1/20 0.32
▸ COPS5 Q92905 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ NOS3 P29474 2/20 0.32
▸ NOS1 P29475 2/20 0.32
▸ NOS2 P35228 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PNMT P11086 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23979549 0.81 PNMT (0.41) PDCD1CD274LMNACYP1A2CYP3A4
SCHEMBL23474009 0.77 NOS3 (0.40) PSMD14COPS5NOS3NOS1NOS2
SCHEMBL23979799 0.72 SCN4A (0.36) PDCD1CD274HTR2AHTR2BLMNA
SCHEMBL27147342 0.70 CYP2D6 (0.45) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL22495173 0.70 CYP2D6 (0.45) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL21071356 0.70 CYP2D6 (0.45) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL30824549 0.70 CYP2D6 (0.45) PDCD1CD274HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL31482194 0.69 LMNA (0.47) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL10934829 0.67 CYP1A2 (0.42) PDCD1CD274HTR2AHTR2CLMNA
SCHEMBL6748371 0.66 LMNA (0.54) LMNANOS3NOS1NOS2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022135470-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 2022-06-30 — — WO disclosed
Send feedback